Polymorphic variants in hereditary pancreatic cancer genes are not associated with pancreatic cancer risk

Cancer Epidemiology Biomarkers and Prevention

Volumn 18, Issue 9, 2009, Pages 2549-2552

  McWilliams, Robert R ^a   Bamlet, William R ^a   De Andrade, Mariza ^a   Rider, David N ^a   Couch, Fergus J ^a   Cunningham, Julie M ^a   Matsumoto, Martha E ^a   Rabe, Kari G ^a   Hammer, Traci J ^a   Petersen, Gloria M ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR 2A;

AGED; ARTICLE; CANCER RISK; CONTROLLED STUDY; FAMILIAL CANCER; FEMALE; GENE EXPRESSION; GENE FUNCTION; GENE INTERACTION; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PALB2 GENE; PANCREAS ADENOCARCINOMA; PANCREAS CANCER; PRIORITY JOURNAL; PRSS1 GENE; PRSS2 GENE; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR GENE;

ADENOCARCINOMA; AGED; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 70349331578     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-09-0605     Document Type: Article

References (14)

1. Kennedy RD, D'Andrea AD. The Fanconi anemia/BRCA pathway: new faces in the crowd. Genes Dev 2005;19:2925-2940
2. Hall JM, Lee MK, Newman B, et al. Linkage of early onset familial breast cancer to chromosome 17q21. Science 1990;250:1684-1689 (Pubitemid 120031871)
3. Wooster R, Bignell G, Lancaster J, et al. Identification of the breast cancer susceptibility gene BRCA2. Nature 1995;378:789-792 (Pubitemid 26004412)
4. Hahn SA, Greenhalf B, Ellis I, et al. BRCA2 germline mutations in familial pancreatic carcinoma. J Natl Cancer Inst 2003;95:214-221 (Pubitemid 36240634)
5. Martin ST, Matsubayashi H, Rogers CD, et al. Increased prevalence of the BRCA2 polymorphic stop codon K3326X among individuals with familial pancreatic cancer. Oncogene 2005;24:3652-3656 (Pubitemid 40756234)
6. Naderi A, Couch FJ. BRCA2 and pancreatic cancer. Int J Gastrointest Cancer 2002;31:99-106.
7. Couch FJ, Johnson M, Rabe K, et al. The contribution of germline mutations in BRCA2 and FANC-C to pancreatic cancer [abstract]. Proc SPORE Invest Workshop 2004. Baltimore (MD).
8. van der Heijden MS, Yeo CJ, Hruban RH, Kern SE. Fanconi anemia gene mutations in young-onset pancreatic cancer. Cancer Res 2003;63:2585-2588
9. Rogers CD, van der Heijden MS, Brune K, et al. The genetics of FANCC and FANCG in familial pancreatic cancer. Cancer Biol Ther 2004;3:167-169 (Pubitemid 41350898)
10. Jones S, Hruban RH, Kamiyama M, et al. Exomic sequencing identifies PALB2 as a pancreatic cancer susceptibility gene. Science 2009;324:217.
11. McWilliams RR, Bamlet WR, de Andrade M, Rider DN, Cunningham JM, Petersen GM. Nucleotide excision repair pathway polymorphisms and pancreatic cancer risk: evidence for role of MMS19L. Prev 2009;18:1295-1302
12. McWilliams RR, Bamlet WR, Cunningham JM, et al. Polymorphisms in DNA repair genes, smoking, and pancreatic adenocarcinoma risk. Cancer Res 2008;68:4928.
13. Carlson CS, Eberle MA, Rieder MJ, Yi Q, Kruglyak L, Nickerson DA. Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium. Am J Hum Genet 2004;74:106-120 (Pubitemid 38085242)
14. Gauderman WJ, Murcray C, Gilliland F, Conti DV. Testing association between disease and multiple SNPs in a candidate gene. Genet Epidemiol 2007;31:383-395 (Pubitemid 47051001)